Because Wegovy lowers blood sugar levels, it may increase the risk of hypoglycemia (low blood sugar), especially when combined with other glucose-lowering medications like insulin in people with diabetes
An experienced clinician seeing these changes in a patient who also lost 15-20% of their body weight would strongly suspect pharmacological intervention
One example is pancreatitis, which is inflammation of the pancreas
Weight loss medications help reduce food noise and suppress your appetite, but they do not do all the work on their own
GLP-1RA in the real world: 1-year compliance and outcomes of semaglutide use in patients with or without previous history of bariatric surgery
Remember that orforglipron is not a peptide, it is a small chemical that can be administered independently of food, which could facilitate its use because it is more convenient for the patient